trending Market Intelligence /marketintelligence/en/news-insights/trending/_EfWDlD8KU75cTih4MDJ6Q2 content esgSubNav
In This List

Fortress Biotech unit closes $94.5M private placement financing

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Fortress Biotech unit closes $94.5M private placement financing

Fortress Biotech Inc.'s subsidiary Mustang Bio, Inc. secured $94.5 million, prior to expenses and fees, in a private placement financing.

The financing allows the company to expand its chimeric antigen receptor engineered T cells immunotherapy pipeline by exploring additional applications in areas outside of the company's initial focus on brain cancer and acute myeloid leukemia.

OPN Capital Markets acted as sole placement agent for the transaction.